INCREASED SERUM APOLIPOPROTEIN(A) IN PATIENTS WITH CHRONIC-RENAL-FAILURE TREATED WITH CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS

被引:31
作者
MURPHY, BG
MCNAMEE, P
DULY, E
HENRY, W
ARCHBOLD, P
TRINICK, T
机构
[1] BELFAST CITY HOSP,DEPT MED,BELFAST BT9 7AD,ANTRIM,NORTH IRELAND
[2] BELFAST CITY HOSP,DEPT CLIN CHEM,BELFAST BT9 7AD,ANTRIM,NORTH IRELAND
[3] ULSTER HOSP,BELFAST,NORTH IRELAND
关键词
CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD); APOLIPOPROTEIN(A); LIPOPROTEIN(A); CHOLESTEROL;
D O I
10.1016/0021-9150(92)90199-Q
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with end-stage renal failure (ESRF) on renal replacement therapy are at significantly increased risk of cardiovascular disease. To determine whether altered concentrations of apolipoprotein(a) (apo(a)), the plasminogen-like protein moiety of the atherogenic particle lipoprotein(a), contributed to this increased risk, apo(a) concentrations were measured in 48 non-diabetic patients with ESRF treated by continuous ambulatory peritoneal dialysis (CAPD) therapy and compared with 65 controls. Apo(a) concentration was increased in CAPD patients compared to controls (geometric mean 419 units/l versus 137 units/l; ratio of means 3.06 (95% CI 1.95-4.80). We conclude that CAPD patients have increased apo(a) concentrations which may contribute to their increased risk of cardiovascular disease.
引用
收藏
页码:53 / 57
页数:5
相关论文
共 25 条
[1]   THE ASSOCIATION BETWEEN SERUM LP(A) CONCENTRATIONS AND ANGIOGRAPHICALLY ASSESSED CORONARY ATHEROSCLEROSIS - DEPENDENCE ON SERUM LDL LEVELS [J].
ARMSTRONG, VW ;
CREMER, P ;
EBERLE, E ;
MANKE, A ;
SCHULZE, F ;
WIELAND, H ;
KREUZER, H ;
SEIDEL, D .
ATHEROSCLEROSIS, 1986, 62 (03) :249-257
[2]  
AVRAM MM, 1988, T AM SOC ART INT ORG, V34, P314
[3]   PROTEIN LOSSES DURING PERITONEAL-DIALYSIS [J].
BLUMENKRANTZ, MJ ;
GAHL, GM ;
KOPPLE, JD ;
KAMDAR, AV ;
JONES, MR ;
KESSEL, M ;
COBURN, JW .
KIDNEY INTERNATIONAL, 1981, 19 (04) :593-602
[4]   THE INFLUENCE OF CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS ON PLASMA-LIPOPROTEINS [J].
BRECKENRIDGE, WC ;
RONCARI, DAK ;
KHANNA, R ;
OREOPOULOS, DG .
ATHEROSCLEROSIS, 1982, 45 (03) :249-258
[5]  
DURRINGTON PN, 1988, LANCET, V1, P1070
[6]   FURTHER CHARACTERIZATION OF THE CELLULAR PLASMINOGEN BINDING-SITE - EVIDENCE THAT PLASMINOGEN-2 AND LIPOPROTEIN-ALPHA COMPETE FOR THE SAME SITE [J].
GONZALEZGRONOW, M ;
EDELBERG, JM ;
PIZZO, SV .
BIOCHEMISTRY, 1989, 28 (06) :2374-2377
[7]   INCREASED PLASMA APOLIPOPROTEIN(A) LEVELS IN IDDM PATIENTS WITH MICROALBUMINURIA [J].
JENKINS, AJ ;
STEELE, JS ;
JANUS, ED ;
BEST, JD .
DIABETES, 1991, 40 (06) :787-790
[8]   KINETICS OF PERITONEAL PROTEIN LOSS DURING CAPD .2. LIPOPROTEIN LEAKAGE AND ITS IMPACT ON PLASMA-LIPID LEVELS [J].
KAGAN, A ;
BARKHAYIM, Y ;
SCHAFER, Z ;
FAINARU, M .
KIDNEY INTERNATIONAL, 1990, 37 (03) :980-990
[9]  
KARADI I, 1989, CLIN CHEM, V35, P2121
[10]   APOLIPOPROTEIN CII AND LIPOPROTEIN-LIPASE IN HUMAN NEPHROTIC SYNDROME [J].
KASHYAP, ML ;
SRIVASTAVA, LS ;
HYND, BA ;
BRADY, D ;
PERISUTTI, G ;
GLUECK, CJ ;
GARTSIDE, PS .
ATHEROSCLEROSIS, 1980, 35 (01) :29-40